SHILPAMEDNSEShilpa Medicare Limited· PharmaceuticalsMinimalNeutral
Announced Tue, 6 Jan · 17:16 IST

Shilpa Medicare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Shilpa Medicare has submitted a certificate under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018 for the quarter ended 31st December 2025. The certificate was issued by Kfin Technologies Limited, the company's Registrar and Share Transfer Agent, and separately filed with NSDL and CDSL (the two depositories). It confirms that details of shares dematerialized (converted to electronic form) and rematerialized (converted back to physical form) during the quarter have been reported to the stock exchanges where Shilpa Medicare is listed (BSE and NSE).

Likely market impact

This is a routine, procedural regulatory filing required of every listed company each quarter and carries no material business or price impact. Investors can take it as a sign of basic compliance housekeeping being kept up to date.